On the afternoon of July 14, 2026, Geng Fuchang, Party Secretary and Vice Chairman of Good Doctor Pharmaceutical Group, and his delegation visited the headquarters of Sichuan FNY Biotechnology Co., Ltd. for inspection and guidance. Geng Yuechang, Deputy General Manager of Good Doctor Pharmaceutical Group and Chairman of FNY; Li Nan, President of FNY and Chairman of FNY Volunteer Federation; You Yan, Vice President of FNY and General Manager of Brand Operation Center accompanied the inspection.

Vice Chairman Geng Fuchang and the delegation first toured the FNY Culture Exhibition Hall, learned about FNY’s core products, enquired about market sales and business progress, and encouraged the company to further leverage industrial chain advantages and strengthen the core competitiveness of its products.

Afterwards, the delegation focused on inspecting Good Doctor Guzheng Chinese Medicine Center and gained an on-site understanding of the FNY · Good Doctor Guzheng Integrated Chinese and Western Medicine Precision Weight Management Project.

The leaders experienced integrated Chinese and Western medicine health examination procedures including the AI tongue diagnosis instrument, body composition analyzer, consultations with TCM specialists and health advisory services. They acquired detailed knowledge of the precision weight management service model featuring TCM syndrome differentiation + technological testing + personalized regimens.

Vice Chairman Geng Fuchang had cordial exchanges with TCM physicians at the Chinese Medicine Center and asked about the technical principles, service workflows and operation status of the project. He recognized the innovative practice of combining traditional TCM theories with modern technologies adopted by the center. He pointed out that weight management represents an important track within the big health industry, and integrated Chinese and Western medicine constitutes a distinctive competitive edge. It is vital to fully capitalize on Good Doctor’s pharmaceutical heritage and TCM inheritance strengths, refine the project system, and deliver scientific and professional health management services to consumers.

During the inspection, Vice Chairman Geng Fuchang affirmed FNY’s solid progress in the big health sector over recent years. He emphasized that as an important component of the big health division under Good Doctor Pharmaceutical Group, FNY must seize development opportunities in the big health industry, adhere to innovation-driven growth, consolidate the foundation of quality, continuously push forward product research and development, brand building and market expansion, and steadily advance high-quality corporate development.

On behalf of the company, Geng Yuechang, Chairman of FNY, expressed gratitude for the care and guidance from group leaders. He stressed that FNY will earnestly implement the instructions and requirements from the group leadership, unite all staff to work in a pragmatic and enterprising manner, deliver solid results in all work, and live up to the trust and expectations of the group.

This inspection demonstrates the group leadership’s attention to and high regard for FNY’s development, greatly inspiring the company team. FNY will closely follow the group’s strategic direction, deepen its layout in the big health industry, focus on delivering high-quality products and services, and promote stable and sound development of all business lines.